Down Syndrome, also known as Trisomy 21, occurs when a person has an extra copy of chromosome 21. It is the most common chromosomal condition, affecting approximately 1 in 700 births. Children with Down syndrome have a wide range of abilities; many walk, talk, attend school, and live full, joyful lives. Key health considerations include congenital heart defects, thyroid issues, hearing and vision differences, increased risk of leukaemia, and higher rates of early-onset Alzheimer's disease in adults. Research in areas such as cognitive enhancement, targeted nutritional interventions, early speech therapy, and inclusive education is rapidly evolving. SpecialCircle Research summarises the most credible studies from sources like PubMed, NIH, and FDA into parent-friendly language - so you can have informed conversations with your child's medical team.
Review article
Scientists recently gathered to share new findings on brain health, memory, and aging in individuals with Down Syndrome.
Source: PubMed (Neuromolecular Medicine)
Clinical trial update
A new clinical trial is recruiting teenagers with Down syndrome to test a medicine that may help with memory and focus.
Source: ClinicalTrials.gov
Clinical trial update
An international clinical trial is currently testing a new oral medication designed to help young people with Down Syndrome manage daily tasks and memory.
Source: ClinicalTrials.gov
Gene therapy
A new technique described in 'Nature' allows for the safe insertion of large pieces of DNA into the genome, which could help deliver gene therapies for Down syndrome.
Source: Nature
Down Syndrome, also known as Trisomy 21, occurs when a person has an extra copy of chromosome 21. It is the most common chromosomal condition, affecting approximately 1 in 700 births. Children with Down syndrome have a wide range of abilities; many walk, talk, attend school, and live full, joyful lives. Key health considerations include congenital heart defects, thyroid issues, hearing and vision differences, increased risk of leukaemia, and higher rates of early-onset Alzheimer's disease in adults. Research in areas such as cognitive enhancement, targeted nutritional interventions, early speech therapy, and inclusive education is rapidly evolving. SpecialCircle Research summarises the most credible studies from sources like PubMed, NIH, and FDA into parent-friendly language - so you can have informed conversations with your child's medical team. SpecialCircle Research summarises studies from PubMed, NIH, FDA, and ClinicalTrials.gov in plain language for parents. This is not medical advice.
Talk to parents who truly understand
SpecialCircle is a free, private community. Ask questions, share what works, and never feel alone.
We use cookies to operate this site and improve your experience. See our Cookie Policy.